Search results
'An Officer and a Gentleman' actor Louis Gossett Jr. died from COPD, report says: What to know about...
Yahoo Canada Style· 6 days agoThis article is for informational purposes only and is not a substitute for professional medical...
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 6 days agoThis growth was primarily driven by strong sales of Dupixent and Libtayo, as well as collaboration...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 5 days agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
What’s Going Around: Seasonal allergies, strep throat, influenza, stomach viruses, COVID
ClickOnDetroit· 6 days agoHere’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities,...
Earnings call: Pulmonx sees 30% sales boost in Q1, eyes $84M annual target By Investing.com
Investing.com· 6 days agoPulmonx Corporation (ticker: LUNG) reported a robust start to 2024 with a 30% increase in worldwide...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 5 days agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi's sBLA for Dupixent for COPD treatment was accepted by the FDA for priority review, highlighting ...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 6 days agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution...
WFRV 5 Green Bay· 20 hours agoMemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County – and one of only two in California – to offer a new, innovative way to treat prostate cancer ...
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use...
Benzinga· 1 day agoFood and Drug Administration (FDA) regarding the development of CannQuit-O for treatment of Opioid Use Disorder (OUD). The pre-IND teleconference included representatives ...
